Introduction: Who Should Undergo Diagnostics

Women experiencing persistent itching, soreness, burning, or discomfort in the vulvar area should seek medical evaluation. These symptoms are especially important to investigate when they persist for weeks or months and do not improve with basic care or over-the-counter treatments.^[1] Squamous cell hyperplasia, also known as lichen simplex chronicus, is often a consequence of chronic scratching that creates abnormal growth of the vulvar skin, so early diagnosis can help prevent the condition from worsening.

It is advisable to consult a healthcare provider when vulvar symptoms interfere with daily activities, sleep, or sexual function. Women who notice changes in the appearance of their vulvar skin—such as thickening, scaling, or color changes—should also seek diagnostic evaluation. Because vulvar discomfort can have many different causes, a proper diagnosis is essential to identify the specific problem and guide appropriate treatment.^[4]

Women who have already been diagnosed with other vulvar skin conditions, such as lichen sclerosus, may also develop squamous cell hyperplasia. In these cases, regular monitoring and follow-up examinations become important to detect any new changes or complications. Healthcare providers may recommend periodic check-ups even when symptoms seem stable, as vulvar skin conditions can evolve over time.^[5]

Diagnostic Methods

The diagnosis of vulvar squamous cell hyperplasia begins with a detailed conversation between the patient and her healthcare provider. The doctor will ask about the duration and nature of symptoms, including when the itching or discomfort began, what makes it better or worse, and whether any treatments have been tried. Understanding the patient’s history helps the healthcare provider narrow down possible causes and plan the most appropriate examination.^[1]

A thorough physical examination of the vulva is the next critical step. The healthcare provider will carefully inspect the vulvar skin, looking for specific changes that might indicate squamous cell hyperplasia. These changes can include thickened skin, altered color, scaling, cracking, or areas of irritation. The examination is typically performed with the patient in a comfortable position and with adequate lighting to ensure all areas can be seen clearly.^[7]

During the examination, doctors may use a special magnifying instrument called a colposcope to get a closer view of the vulvar tissue. This device allows them to see details that might not be visible to the naked eye. The colposcope does not touch the skin and is simply used for better visualization of any abnormal areas.^[11]

Appearance of Squamous Cell Hyperplasia

Squamous cell hyperplasia has characteristic features that help healthcare providers recognize it during examination. The affected vulvar skin often appears thickened and may have a leathery texture. The color can vary, with some areas appearing gray, white, or darker than surrounding skin. In many cases, the skin shows signs of scratching, such as marks or linear patterns where the patient has rubbed the area.^[1]

The condition can affect different parts of the vulva, though it commonly appears on the outer lips (labia majora). Some women develop patches in multiple locations, while others have just one affected area. The skin may show scaling or flaking, similar to very dry skin elsewhere on the body. In some instances, there may be small cracks or breaks in the skin where persistent scratching has damaged the surface.^[15]

The Role of Biopsy

While the physical appearance of the vulva can suggest squamous cell hyperplasia, a biopsy is often necessary to confirm the diagnosis and rule out other conditions. A biopsy involves taking a small sample of tissue from the affected area so it can be examined under a microscope in a laboratory. This is the most definitive way to establish what is happening at the cellular level in the skin.^[7]

During a biopsy, the healthcare provider numbs the area with a local anesthetic so the patient does not feel pain during the procedure. A small piece of tissue, usually just a few millimeters in size, is then removed using a special instrument. The sample is sent to a laboratory where a specialist called a pathologist examines the tissue structure and cellular changes. This microscopic examination reveals the characteristic features of squamous cell hyperplasia, which include thickening of the outer layer of skin cells.^[11]

The biopsy serves several important purposes beyond confirming squamous cell hyperplasia. It helps doctors distinguish this condition from other vulvar disorders that can look similar, such as lichen sclerosus, lichen planus, or more serious conditions. Some vulvar conditions have overlapping symptoms and appearances, making it difficult to tell them apart without examining the tissue microscopically. Additionally, a biopsy can identify if there are any abnormal or precancerous cells present, which would require different treatment approaches.^[2]

Additional Diagnostic Tests

In some cases, healthcare providers may perform additional tests to identify underlying factors contributing to the vulvar symptoms. If an infection is suspected as a trigger for the scratching, samples may be collected to test for yeast, bacteria, or other organisms. These tests help rule out infectious causes that might be contributing to the itching and irritation.^[15]

Doctors may also assess whether irritants or allergens are playing a role in the patient’s symptoms. This involves asking detailed questions about products used in the genital area, including soaps, detergents, feminine hygiene products, and topical medications. Sometimes, identifying and removing these irritants is an essential part of both diagnosis and treatment. In selected cases, allergy testing may be recommended if contact dermatitis is suspected as a contributing factor.^[7]

Blood tests are not typically used to diagnose squamous cell hyperplasia itself, but they may be ordered if the healthcare provider suspects that an underlying medical condition, such as diabetes or an immune system disorder, is contributing to the vulvar symptoms. These tests provide additional information about the patient’s overall health and can help guide comprehensive treatment planning.^[13]

Distinguishing from Other Conditions

One of the key challenges in diagnosing vulvar conditions is that many different disorders can produce similar symptoms of itching, irritation, and skin changes. Healthcare providers must carefully distinguish squamous cell hyperplasia from other vulvar skin conditions that require different treatments. This process of differentiation is called making a differential diagnosis.^[4]

Lichen sclerosus, for example, is another condition that causes white patches and itching of the vulva but has different underlying causes and tissue changes. Unlike squamous cell hyperplasia, which results from chronic scratching and rubbing, lichen sclerosus is thought to involve autoimmune factors and creates characteristic thinning of the skin. Both conditions can occur together in the same patient, making careful examination and biopsy even more important.^[5]

Vulvar intraepithelial neoplasia, or VIN, represents precancerous changes in vulvar skin cells. While VIN can sometimes cause itching, its underlying cellular changes are quite different from those seen in squamous cell hyperplasia. VIN requires more aggressive monitoring and treatment because of its potential to progress to cancer. A biopsy is essential to distinguish between these conditions, as they can occasionally look similar on visual examination.^[2]

Other conditions that may need to be ruled out include psoriasis, eczema, contact dermatitis, and various infections. Each of these has its own characteristic features, but there can be overlap in symptoms and appearance. This is why a comprehensive approach—combining patient history, physical examination, and when necessary, biopsy—is crucial for accurate diagnosis.^[13]

Diagnostics for Clinical Trial Qualification

When patients with vulvar squamous cell hyperplasia are considered for participation in clinical trials testing new treatments, specific diagnostic criteria must be met to ensure the study includes appropriate participants. Clinical trials typically require confirmed diagnoses based on established standards, and this usually means having both clinical findings and biopsy results that clearly demonstrate the condition.^[6]

Most clinical trials involving vulvar conditions require a biopsy-proven diagnosis. This means that before a patient can enroll, tissue samples must have been examined by a pathologist who confirmed the presence of squamous cell hyperplasia. The biopsy report provides objective evidence of the condition and ensures that all participants in the study actually have the disease being investigated. This standardization is important for the validity of research results.^[6]

Clinical trials may also have specific requirements about the severity and extent of the condition. Researchers might measure the size of affected areas, assess the degree of symptoms using standardized scales, or document the thickness of the skin. These baseline measurements allow researchers to track whether treatments are working by comparing the patient’s condition before and after receiving the experimental therapy.^[8]

Some research studies require documentation that other potential causes of vulvar symptoms have been ruled out. This might involve testing for infections, checking hormone levels, or performing additional biopsies to confirm that the diagnosis is purely squamous cell hyperplasia without overlapping conditions. These requirements help researchers understand exactly how the treatment affects the specific disease being studied.^[14]

Clinical trials may also require regular follow-up examinations and repeat biopsies during the study period to monitor how the disease responds to treatment. These procedures provide the data researchers need to determine if a new treatment is effective and safe. While this means more frequent clinic visits and diagnostic procedures, it also allows participants to receive close medical monitoring throughout the study.^[6]